JPMORGAN CHASE & CO - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is ATXI and the CUSIP is 05360L205. A total of 20 filers reported holding AVENUE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
1
-99.8%
0.00%
Q2 2021$2,000
-98.2%
665
-96.3%
0.00%
Q1 2021$110,000
+8.9%
18,210
+6.5%
0.00%
Q4 2020$101,000
+94.2%
17,102
+260.2%
0.00%
Q3 2020$52,000
-10.3%
4,748
-12.2%
0.00%
Q2 2020$58,0005,4090.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
EMFO, LLC 24,000$12,0000.01%
Virtu Financial LLC 58,004$28,0000.00%
TWO SIGMA SECURITIES, LLC 52,813$25,0000.00%
B. Riley Wealth Advisors, Inc. 60,330$30,0000.00%
BNP PARIBAS FINANCIAL MARKETS 8$4,0000.00%
BANK OF AMERICA CORP /DE/ 104$00.00%
WELLS FARGO & COMPANY/MN 48,062$23,0000.00%
NORTHERN TRUST CORP 13,767$7,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 84,033$40,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders